57 related articles for article (PubMed ID: 23919857)
1. Effects of a combined oral contraceptive containing oestradiol valerate/dienogest on hormone withdrawal-associated symptoms: results from the multicentre, randomised, double-blind, active-controlled HARMONY II study.
Macìas G; Merki-Feld GS; Parke S; Mellinger U; Serrani M
J Obstet Gynaecol; 2013 Aug; 33(6):591-6. PubMed ID: 23919857
[TBL] [Abstract][Full Text] [Related]
2. Venous Thromboembolic Risk of Estradiol Valerate-Dienogest Compared with Ethinyl Estradiol-Levonorgestrel Combined Oral Contraceptives.
Bauerfeind A; von Stockum S; Boehnke T; Heinemann K
Obstet Gynecol; 2024 Mar; 143(3):431-434. PubMed ID: 38227942
[TBL] [Abstract][Full Text] [Related]
3. Oestrogens in oral contraception: considerations for tailoring prescription to women's needs.
Fruzzetti F; Fidecicchi T; Gambacciani M
Eur J Contracept Reprod Health Care; 2024 Jun; 29(3):93-102. PubMed ID: 38683756
[TBL] [Abstract][Full Text] [Related]
4. Change to either a nonandrogenic or androgenic progestin-containing oral contraceptive preparation is associated with improved sexual function in women with oral contraceptive-associated sexual dysfunction.
Davis SR; Bitzer J; Giraldi A; Palacios S; Parke S; Serrani M; Mellinger U; Nappi RE
J Sex Med; 2013 Dec; 10(12):3069-79. PubMed ID: 24034466
[TBL] [Abstract][Full Text] [Related]
5. Fertility and combined oral contraceptives - unintended pregnancies and planned pregnancies following oral contraceptive use - results from the INAS-SCORE study.
Barnett C; Hagemann C; Dinger J; Do Minh T; Heinemann K
Eur J Contracept Reprod Health Care; 2017 Feb; 22(1):17-23. PubMed ID: 27749101
[TBL] [Abstract][Full Text] [Related]
6. Unintended pregnancy rates differ according to combined oral contraceptive - results from the INAS-SCORE study.
Barnett C; Dinger J; Minh TD; Heinemann K
Eur J Contracept Reprod Health Care; 2019 Aug; 24(4):247-250. PubMed ID: 31204884
[No Abstract] [Full Text] [Related]
7. Impact of estrogen type on cardiovascular safety of combined oral contraceptives.
Dinger J; Do Minh T; Heinemann K
Contraception; 2016 Oct; 94(4):328-39. PubMed ID: 27343748
[TBL] [Abstract][Full Text] [Related]
8. Haemostatic and metabolic impact of estradiol pills and drospirenone-containing ethinylestradiol pills vs. levonorgestrel-containing ethinylestradiol pills: A literature review.
Lete I; Chabbert-Buffet N; Jamin C; Lello S; Lobo P; Nappi RE; Pintiaux A
Eur J Contracept Reprod Health Care; 2015; 20(5):329-43. PubMed ID: 26007631
[TBL] [Abstract][Full Text] [Related]
9. Contraception with estradiol valerate and dienogest: adherence to the method.
Fruzzetti F; Paoletti AM; Fidecicchi T; Posar G; Giannini R; Gambacciani M
Open Access J Contracept; 2019; 10():1-6. PubMed ID: 31191048
[No Abstract] [Full Text] [Related]
10. Male and female sex hormones in primary headaches.
Delaruelle Z; Ivanova TA; Khan S; Negro A; Ornello R; Raffaelli B; Terrin A; Mitsikostas DD; Reuter U;
J Headache Pain; 2018 Nov; 19(1):117. PubMed ID: 30497379
[TBL] [Abstract][Full Text] [Related]
11. Sex differences in vascular physiology and pathophysiology: estrogen and androgen signaling in health and disease.
Boese AC; Kim SC; Yin KJ; Lee JP; Hamblin MH
Am J Physiol Heart Circ Physiol; 2017 Sep; 313(3):H524-H545. PubMed ID: 28626075
[TBL] [Abstract][Full Text] [Related]
12. Continuation rates, bleeding profile acceptability, and satisfaction of women using an oral contraceptive pill containing estradiol valerate and dienogest versus a progestogen-only pill after switching from an ethinylestradiol-containing pill in a real-life setting: results of the CONTENT study.
Briggs P; Serrani M; Vogtländer K; Parke S
Int J Womens Health; 2016; 8():477-487. PubMed ID: 27695365
[TBL] [Abstract][Full Text] [Related]
13. Perimenstrual asthma: from pathophysiology to treatment strategies.
Graziottin A; Serafini A
Multidiscip Respir Med; 2016; 11():30. PubMed ID: 27482380
[TBL] [Abstract][Full Text] [Related]
14. Choosing a combined oral contraceptive pill.
Stewart M; Black K
Aust Prescr; 2015 Feb; 38(1):6-11. PubMed ID: 26648603
[TBL] [Abstract][Full Text] [Related]
15. Hormone withdrawal-associated symptoms with ethinylestradiol 20 μg/drospirenone 3 mg (24/4 regimen) versus ethinylestradiol 20 μg/desogestrel 150 μg (21/7 regimen).
Bitzer J; Banal-Silao MJ; Ahrendt HJ; Restrepo J; Hardtke M; Wissinger-Graefenhahn U; Trummer D
Int J Womens Health; 2015; 7():501-9. PubMed ID: 26056491
[TBL] [Abstract][Full Text] [Related]
16. Noncontraceptive benefits of the estradiol valerate/dienogest combined oral contraceptive: a review of the literature.
Nappi RE; Serrani M; Jensen JT
Int J Womens Health; 2014; 6():711-8. PubMed ID: 25120376
[TBL] [Abstract][Full Text] [Related]
17. Migraine and estrogen.
Chai NC; Peterlin BL; Calhoun AH
Curr Opin Neurol; 2014 Jun; 27(3):315-24. PubMed ID: 24792340
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
